🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the producers of Tylenol, alleging the firms concealed safety concerns that the medication presented to children's neurological development.

The lawsuit arrives a month after President Donald Trump publicized an unproven link between using acetaminophen - alternatively called acetaminophen - throughout gestation and autism in offspring.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever approved for pregnant women, and Kenvue, which currently produces it.

In a official comment, he said they "misled consumers by making money from discomfort and promoting medication regardless of the risks."

Kenvue states there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These companies misled for generations, intentionally threatening millions to increase profits," Paxton, from the Republican party, stated.

The manufacturer commented that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the health of US mothers and children."

On its website, Kenvue also mentioned it had "regularly reviewed the applicable studies and there is no credible data that shows a established connection between consuming paracetamol and autism spectrum disorder."

Groups acting on behalf of physicians and medical practitioners agree.

The American College of Obstetricians and Gynecologists has declared paracetamol - the main ingredient in acetaminophen - is one of the few options for women during pregnancy to treat pain and fever, which can present significant medical dangers if not addressed.

"In more than two decades of investigation on the use of paracetamol in pregnancy, no reliable research has conclusively proven that the consumption of acetaminophen in any trimester of gestation causes neurodevelopmental disorders in offspring," the group stated.

This legal action references latest statements from the Trump administration in asserting the medication is allegedly unsafe.

Recently, the former president caused concern from health experts when he told pregnant women to "struggle intensely" not to consume acetaminophen when unwell.

The FDA then published an announcement that medical professionals should contemplate reducing the consumption of Tylenol, while also stating that "a causal relationship" between the drug and autism in children has not been proven.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would establish the source of autism in a matter of months.

But authorities warned that finding a sole reason of autism spectrum disorder - thought by researchers to be the outcome of a intricate combination of genetic and surrounding conditions - would prove challenging.

Autism is a type of enduring cognitive variation and impairment that influences how persons encounter and relate to the surroundings, and is diagnosed using doctors' observations.

In his legal document, the attorney general - who supports Trump who is campaigning for federal office - asserts Kenvue and J&J "deliberately disregarded and sought to suppress the science" around paracetamol and autism.

The case aims to force the firms "remove any promotional materials" that states Tylenol is reliable for expectant mothers.

The court case mirrors the grievances of a group of guardians of young ones with autism and ADHD who filed suit against the manufacturers of Tylenol in 2022.

Judicial authorities rejected the lawsuit, declaring research from the family's specialists was not conclusive.